We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.
People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
LONDON (Reuters) - Leading drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.... (Reuters) - With the closest known U.S. cases of Ebola diagnosed about 160 miles away in Dallas, Cary Griffin is taking no chances.... NEW YORK (Reuters) - The United States ratcheted up its safeguards against Ebola on Tuesday, requiring travelers from three countries at the center of an epidemic in West Africa to fly into one of five major airports conducting enhanced screening for the virus.... PARIS (Reuters) - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research.... BOSTON (Reuters) - The U.S. Department of Homeland Security is investigating about two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters.... (Reuters) - Biogen Idec Inc on Wednesday reported much higher-than-expected third-quarter profit and the company raised its full-year earnings forecast, even as its big-selling new oral multiple sclerosis drug Tecfidera fell short of lofty Wall Street estimates for the first time.... LONDON (Reuters) - GlaxoSmithKline kept its dividend unchanged for the third quarter, breaking a run of steadily rising payouts, as U.S. pricing pressure on its top-selling lung drug Advair eroded sales and profit.... WASHINGTON (Reuters) - President Barack Obama and his senior advisers will meet on Wednesday with Ron Klain, the new Ebola "czar" charged with coordinating the U.S. response to the Ebola outbreak in West Africa that has ravaged three countries and alarmed Americans.... NEW YORK (Reuters) - The medical status of nurse Nina Pham, who contracted Ebola when she helped treat the first patient to be diagnosed with the disease on U.S. soil, was upgraded to good from fair on Tuesday, the National Institutes of Health (NIH) announced.... WASHINGTON (Reuters) - Nearly three-fourths of Americans support a ban on civilian air travel in and out of the West African countries that have experienced an Ebola outbreak, a new Reuters/Ipsos poll shows, suggesting growing pressure on President Barack Obama over the issue....